Relcof Dm
NDC Package 35573-321-16

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Relcof Dm is a . Marketed by Burel Pharmaceuticals, Inc, this product is identified by NDC 35573-321 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
35573-321-16
Package Description
473 mL in 1 BOTTLE
Product Code
35573-321
11-Digit Billing Format
35573032116
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
473 ML

Clinical Specifications

Proprietary Name
Relcof Dm
Dosage Form
-

Regulatory & Marketing

Labeler Name
Burel Pharmaceuticals, Inc
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
03-22-2016
End Marketing Date
08-01-2017
Listing Expiration
08-01-2017
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 35573-321-16 identifies a specific commercial package of 473 ml in 1 bottle of Relcof Dm, labeled by Burel Pharmaceuticals, Inc. This product is billed per "ML" milliliter and contains an estimated amount of 473 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Burel Pharmaceuticals, Inc on March 22, 2016. The current certification is valid through August 01, 2017.

How is this Burel Pharmaceuticals, Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 35573032116. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 473 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
35573-321-16
11-Digit CMS (5-4-2)
35573-0321-16

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.